- Home
- ALLO vs KIDS Comparison
ALLO vs KIDS Comparison
Compare ALLO & KIDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALLO | KIDS |
|---|---|---|
| Founded | 2017 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 452.6M | 588.8M |
| IPO Year | 2018 | 2016 |
Fundamental Metrics
Financial Performance| Metric | ALLO | KIDS |
|---|---|---|
| Price | $1.25 | $24.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 9 |
| Target Price | $9.00 | ★ $27.22 |
| AVG Volume (30 Days) | ★ 5.3M | 194.9K |
| Earning Date | 11-05-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.09 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $98,049,000.00 |
| Revenue This Year | N/A | $12.96 |
| Revenue Next Year | $255.46 | $11.92 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 37.95 |
| 52 Week Low | $1.04 | $14.42 |
| 52 Week High | $4.46 | $26.74 |
Technical Indicators
Market Signals| Indicator | ALLO | KIDS |
|---|---|---|
| Relative Strength Index (RSI) | 25.84 | 64.81 |
| Support Level | $1.22 | $21.13 |
| Resistance Level | $2.22 | $26.74 |
| Average True Range (ATR) | 0.08 | 0.75 |
| MACD | 0.00 | 0.30 |
| Stochastic Oscillator | 25.00 | 87.40 |
Price Performance
Historical ComparisonAbout ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.